The PI3K p110δ regulates expression of CD38 on regulatory T cells
about
Functional Mechanisms of Treg in the Context of HIV Infection and the Janus Face of Immune SuppressionInactivation of PI(3)K p110δ breaks regulatory T-cell-mediated immune tolerance to cancerTargeting PI3K in cancer: impact on tumor cells, their protective stroma, angiogenesis and immunotherapyTargeting regulatory T cells to improve vaccine immunogenicity in early life.Ectonucleotidase CD38 demarcates regulatory, memory-like CD8+ T cells with IFN-γ-mediated suppressor activities.Nanotechnology as a New Therapeutic Approach to Prevent the HIV-Infection of Treg Cells.Large granular lymphocytes are universally increased in human, macaque, and feline lentiviral infectionCD38-Expressing Myeloid-Derived Suppressor Cells Promote Tumor Growth in a Murine Model of Esophageal Cancer.Reduced Plasmodium Parasite Burden Associates with CD38+ CD4+ T Cells Displaying Cytolytic Potential and Impaired IFN-γ ProductionThe Therapeutic Potential for PI3K Inhibitors in Autoimmune Rheumatic DiseasesAltered AKT1 and MAPK1 gene expression on peripheral blood mononuclear cells and correlation with T-helper-transcription factors in systemic lupus erythematosus patientsTargeting Treg signaling for the treatment of autoimmune diseasesICOSL expression in human bone marrow-derived mesenchymal stem cells promotes induction of regulatory T cells.The Role of the PI3K Signaling Pathway in CD4(+) T Cell Differentiation and Function.Role of inositol poly-phosphatases and their targets in T cell biology.PI3K inhibitors in inflammation, autoimmunity and cancer.Targeting B Cell Signaling in Chronic Lymphocytic Leukemia.PI3Kδ Regulates the Magnitude of CD8+ T Cell Responses after Challenge with Listeria monocytogenes.Does the PI3K pathway promote or antagonize regulatory T cell development and function?Tuning IL-2 signaling by ADP-ribosylation of CD25.Pten loss in CD4 T cells enhances their helper function but does not lead to autoimmunity or lymphoma.Regulation of T cell alloimmunity by PI3Kγ and PI3Kδ.CD38 knockout suppresses tumorigenesis in mice and clonogenic growth of human lung cancer cells.Regulatory T Cells: Molecular and Cellular Basis for Immunoregulation.CD38 promotes pristane-induced chronic inflammation and increases susceptibility to experimental lupus by an apoptosis-driven and TRPM2-dependent mechanism.CD38+ M-MDSC expansion characterizes a subset of advanced colorectal cancer patients.The impact of PI3K inhibitors on breast cancer cell and its tumor microenvironment.CD69 enhances immunosuppressive function of regulatory T-cells and attenuates colitis by prompting IL-10 productionRecycling endosome-dependent and -independent mechanisms for IL-10 secretion in LPS-activated macrophagesThe Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus
P2860
Q26744626-32269FDB-7489-46EA-A105-E65BBB4C9568Q28241808-B2F720BC-2CC0-43E6-892E-497F4EA125D0Q29248893-DEB48E7A-5DB0-4192-8BC1-4530CD7F4A2AQ34164169-98E54ED4-8E1F-4697-AC98-F1A971F580ADQ34428428-7864C96E-7A7C-4084-8C19-5554DD306F2AQ35897923-3AA84492-719B-42BB-AB8D-B8C6842308F5Q36096177-24BEF844-D52E-4279-96EB-F70B572F820AQ36118086-B3049460-458A-4799-9161-E2F3F7920EE8Q36143186-BF86CC86-D909-42B4-80E7-BFDE7B501C89Q36286414-E5A145E0-392D-4DC4-837C-C06D80859C1BQ36355671-0CA1161A-B567-499A-A5EF-3295BC8433B3Q36372616-896200AF-7383-452F-89CA-3E51094003EAQ37698693-CC0E418A-15BF-4760-BF67-AF8277F6F73BQ38035848-BC116415-EFFA-46CB-80AD-81533575EDBDQ38143834-9E70BB32-A44D-4FFA-B79D-650C5E55E2A7Q38532898-31001DD1-BBEF-4213-8DDD-74E663133C16Q38654101-FB2CE1A4-C2D5-42FF-B434-9956BFCC8603Q41030989-F1B2E148-5C71-4232-8E5C-DA0EC714AD0FQ41864874-353F0642-D895-49EB-BD0D-F5A5D43C868DQ41892598-63BDE5BC-D748-469A-A21B-B4861D36E436Q42206056-BC164102-B641-43DA-96C8-BC174F01ACBFQ42378867-57992E3F-8E82-4131-AA37-8676A572DF15Q47307445-CB65A57C-9ED6-4F9D-B0A1-18D5E5DBDB57Q48668293-DDF24B83-9F2E-4D32-B0FD-516C9066AE47Q49789227-AD12622D-02F5-4D53-8977-4A564BF30EC3Q52644017-E7542BFE-8B1F-4112-95CA-429E6277E56BQ55435506-001FC7DB-E14E-4B8F-99FC-ED9CC70D073AQ56889158-08C6C48A-FD85-40C5-A62E-EF4F06D7F4D6Q58009872-76827B24-E13B-4BF9-A7FC-6C2F41F8989EQ59133987-C83D186E-10A8-4B18-94A6-702FC3199F48
P2860
The PI3K p110δ regulates expression of CD38 on regulatory T cells
description
2011 nî lūn-bûn
@nan
2011 թուականի Մարտին հրատարակուած գիտական յօդուած
@hyw
2011 թվականի մարտին հրատարակված գիտական հոդված
@hy
2011年の論文
@ja
2011年論文
@yue
2011年論文
@zh-hant
2011年論文
@zh-hk
2011年論文
@zh-mo
2011年論文
@zh-tw
2011年论文
@wuu
name
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@ast
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@en
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@nl
type
label
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@ast
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@en
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@nl
prefLabel
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@ast
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@en
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@nl
P2093
P2860
P3181
P1433
P1476
The PI3K p110δ regulates expression of CD38 on regulatory T cells
@en
P2093
Dalya R Soond
Daniel T Patton
Wendy C Rowan
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0017359
P407
P577
2011-03-01T00:00:00Z